GRAIL, Inc. Income Tax Expense
GRAIL, Inc. (GRAL) reported Income Tax Expense of -$56.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- GRAIL, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was -$56.46M.
- GRAIL, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was -$34.34M.
- GRAIL, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$17.34M.
- GRAIL, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$29.74M.
- GRAIL, Inc. income tax expense (benefit) for fiscal 2025 was -$126.15M.
- GRAIL, Inc. income tax expense (benefit) for fiscal 2024 was -$135.36M.
- GRAIL, Inc. income tax expense (benefit) for fiscal 2023 was -$41.95M.
- GRAIL, Inc. income tax expense (benefit) for fiscal 2023 was -$42.29M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$56.46M 10-Q · filed 2026-08-06 | -$90.80M 10-Q · filed 2026-08-06 | -$108.14M derived: sum of 3 quarters · filed 2026-08-06 | -$137.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$34.34M 10-Q · filed 2026-05-07 | -$51.68M derived: sum of 2 quarters · filed 2026-05-07 | -$81.42M derived: sum of 3 quarters · filed 2026-05-07 | -$120.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$17.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$47.08M derived: sum of 2 quarters · filed 2026-03-12 | -$85.95M derived: sum of 3 quarters · filed 2026-08-06 | -$126.15M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$29.74M 10-Q · filed 2025-11-13 | -$68.61M derived: sum of 2 quarters · filed 2026-08-06 | -$108.81M 10-Q · filed 2025-11-13 | -$138.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$38.87M 10-Q · filed 2026-08-06 | -$79.07M 10-Q · filed 2026-08-06 | -$109.00M derived: sum of 3 quarters · filed 2026-08-06 | -$155.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$40.20M 10-Q · filed 2026-05-07 | -$70.13M derived: sum of 2 quarters · filed 2026-05-07 | -$116.85M derived: sum of 3 quarters · filed 2026-05-07 | -$169.99M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$76.65M derived: sum of 2 quarters · filed 2026-03-12 | -$129.79M derived: sum of 3 quarters · filed 2026-03-12 | -$135.36M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$46.72M 10-Q · filed 2025-11-13 | -$99.86M derived: sum of 2 quarters · filed 2025-11-13 | -$105.43M 10-Q · filed 2025-11-13 | -$110.93M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$53.14M 10-Q · filed 2025-08-13 | -$58.71M 10-Q · filed 2025-08-13 | -$64.21M derived: sum of 3 quarters · filed 2026-03-12 | -$82.82M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$5.57M 10-Q · filed 2025-05-14 | -$11.07M derived: sum of 2 quarters · filed 2026-03-12 | -$29.68M derived: sum of 3 quarters · filed 2026-03-12 | -$39.47M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$24.11M derived: sum of 2 quarters · filed 2026-03-12 | -$33.91M derived: sum of 3 quarters · filed 2026-03-12 | -$41.95M 10-K · filed 2025-03-05 |
| 2023-10-01 | -$18.61M 10-Q · filed 2024-11-13 | -$28.41M derived: sum of 2 quarters · filed 2024-11-13 | -$36.45M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$9.80M 10-Q · filed 2024-08-13 | -$17.84M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | -$42.29M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |